Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjhemonc logo
VJRegenMed
Logo
  • Home (current)
  • Specialties
    Hematology
    Oncology
    Musculoskeletal Disorder
    Rare Disease
    Metabolic Disorder
    Cardiovascular Disease
    Ophthalmology
    Neurology
    Infectious Disease
    View all Specialties
  • Technologies
    Cell Therapy
    MSC
    iPSC
    Gene Therapy
    Genome Editing
    Extracellular Vesicles
    CAR-T Therapy
    TCR Therapy
    Tissue-Engineering & Biomaterials
    View all Technologies
  • Topics
    Treatment
    Immuno-Oncology
    Trial Updates
    Perspectives
    Manufacturing
    COVID-19
    View all Topics
  • Conferences
    ASH 2022
    TCT 2022
    Meeting on the Med 2022
    ICLE 2022
    Advanced Therapies Week 2022
    TERMIS 2021
    ESGCT 2021
    Meeting on the Mesa 2021
    Advanced Therapies 2021
    View all Conferences
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Automation

Implementing automation technology in the CGT space 1:28
Implementing automation technology in the CGT space
Saskia Rösch • 6 Apr 2022
Utilizing flow cytometry in CAR T-cell research 3:10
Utilizing flow cytometry in CAR T-cell research
Saskia Rösch • 6 Apr 2022
Overcoming manufacturing issues in gene therapies for rare diseases 1:38
Overcoming manufacturing issues in gene therapies for rare diseases
John Maslowski • 27 Jan 2022
Innovations in treating rare diseases with gene therapies 2:12
Innovations in treating rare diseases with gene therapies
John Maslowski • 27 Jan 2022
Meeting the growing demand for gene therapy manufacturing 1:36
Meeting the growing demand for gene therapy manufacturing
John Maslowski • 27 Jan 2022
Advances in T cell metabolic profiling 2:33
Advances in T cell metabolic profiling
Daniel Gebhard • 31 Mar 2022
Adapting to challenges in manufacturing cell therapies for solid tumors 1:58
Adapting to challenges in manufacturing cell therapies for solid tumors
Christopher Ballas • 27 Jan 2022
The role of automation in manufacturing CAR T-cells 1:44
The role of automation in manufacturing CAR T-cells
Bruce Levine • 27 Jan 2022
Strategies to increase cell therapy manufacturing capabilities 1:25
Strategies to increase cell therapy manufacturing capabilities
Shannon Eaker • 27 Jan 2022
Addressing issues in patients accessing advanced therapies 3:32
Addressing issues in patients accessing advanced therapies
Jason Foster • 27 Jan 2022
Improving the scalability of advanced therapies 2:27
Improving the scalability of advanced therapies
Delara Motlagh • 27 Jan 2022
Regulatory challenges in automating CGT manufacturing 1:04
Regulatory challenges in automating CGT manufacturing
Delara Motlagh • 27 Jan 2022
Optimizing CGT manufacturing processes with digitalization 1:46
Optimizing CGT manufacturing processes with digitalization
Kwok Pang • 26 Jan 2022
Achieving operational excellence in CGT through automation 4:29
Achieving operational excellence in CGT through automation
Sharon Brownlow • 26 Jan 2022
Upscaling cell and gene therapy manufacturing 1:18
Upscaling cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
CMC challenges in cell and gene therapy manufacturing 1:29
CMC challenges in cell and gene therapy manufacturing
Michael Lehmicke • 26 Jan 2022
  • 1
  • 2
  • Next
Journal Pages
  • Specialties
  • Technologies
  • Topics
  • Conferences
Newsletter

Receive the latest news and videos from VJRegenMed via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJRegenMed logo
The content of VJRegenMed is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy